Literature DB >> 10550523

Experimental autoimmune cystitis: further characterization and serum autoantibodies.

S Mitra1, A Dagher, R Kage, R K Dagher, J Luber-Narod.   

Abstract

Previously, we described an animal model for interstitial cystitis (IC), experimental autoimmune cystitis (EAC) [Luber-Narod et al. Urol Res 24:367]. Further characterization of animals with EAC indicates that peak and mean urinary frequency are elevated compared with sham-injected controls and that the disease progresses with at least two cycles of exacerbations and remissions. We had shown evidence suggesting EAC to be autoimmune in nature. In this paper, we identify serum autoantibodies from 9/10 EAC animals which bind to a protein specific to rat bladder with a relative molecular weight of 12-kDa. Such autoantibodies are absent in 12/13 normal and sham-injected animals as well as animals which fail to develop EAC despite disease induction. These findings suggest that EAC is a reproducible model of cyclical increases of urinary frequency, and that a 12-kDa antigen is the target of autoantibodies which correlate with those elevations. Identification of this target antigen may explain the pathogenesis of increased urinary frequency in these animals and potentially in IC as well.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550523     DOI: 10.1007/s002400050162

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  6 in total

1.  Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.

Authors:  Xiangrong Cui; Xuan Jing; Susan K Lutgendorf; Catherine S Bradley; Andrew Schrepf; Bradley A Erickson; Vincent A Magnotta; Timothy J Ness; Karl J Kreder; Michael A O'Donnell; Yi Luo
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-15

Review 2.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

3.  Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

Authors:  Ronald Kim; Wujiang Liu; Xiaohong Chen; Karl J Kreder; Yi Luo
Journal:  J Biomed Biotechnol       Date:  2010-11-11

4.  Urothelial antigen-specific CD4+ T cells function as direct effector cells and induce bladder autoimmune inflammation independent of CD8+ T cells.

Authors:  W Liu; X Chen; D P Evanoff; Y Luo
Journal:  Mucosal Immunol       Date:  2011-01-26       Impact factor: 7.313

5.  Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.

Authors:  Xu Wang; Wujiang Liu; Michael O'Donnell; Susan Lutgendorf; Catherine Bradley; Andrew Schrepf; Liwei Liu; Karl Kreder; Yi Luo
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

6.  Sub-noxious Intravesical Lipopolysaccharide Triggers Bladder Inflammation and Symptom Onset in A Transgenic Autoimmune Cystitis Model: A MAPP Network Animal Study.

Authors:  Paul Kogan; Suming Xu; Yaoqin Wang; Michael A O'Donnell; Susan K Lutgendorf; Catherine S Bradley; Andrew Schrepf; Karl J Kreder; Yi Luo
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.